LISMARY CAMPOS-PADILLA PHARMD
Prescription History 1962796607
Pharmacist in San Juan, PR
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for LISMARY CAMPOS-PADILLA PHARMD, an active Pharmacist specialist practicing in San Juan, PR. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 374 documented patient claims. Among these therapy options, the most frequently utilized medication is Shingrix, which accounts for 172 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other PR PrescribersVs. PR Avg |
|---|---|---|---|
| ShingrixVaricella-Zoster Ge/As01b/Pf | 172 | $203.63 | ▲ More than typical |
In 2023, this provider wrote 172 Medicare prescriptions for Shingrix, about 6.6 times the volume of the typical Puerto Rico prescriber of this medication (26). Medicare paid an average of $203.63 per fill, versus $191.48 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PR prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 172 30-Day Fills standardized to 30-day supplies 172 Days of Medication total across all patients in 2023 | |||
| Boostrix TdapDiphth,pertuss(Acell),tet Vac | 76 | $66.35 | ▲ More than typical |
In 2023, this provider wrote 76 Medicare prescriptions for Boostrix Tdap, about 1.6 times the volume of the typical Puerto Rico prescriber of this medication (47). Medicare paid an average of $66.35 per fill, versus $62.08 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PR prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 76 30-Day Fills standardized to 30-day supplies 76 Days of Medication total across all patients in 2023 | |||
| ArexvyRsvpref3 Antigen/As01e/Pf | 66 | $303.88 | – No State Data |
In 2023, this provider wrote 66 Medicare prescriptions for Arexvy. Medicare paid an average of $303.88 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $303.88 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 66 30-Day Fills standardized to 30-day supplies 66 Days of Medication total across all patients in 2023 | |||
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 60 | $318.20 | – No State Data |
In 2023, this provider wrote 60 Medicare prescriptions for Abrysvo. Medicare paid an average of $318.20 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $318.20 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 60 30-Day Fills standardized to 30-day supplies 60 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for LISMARY CAMPOS-PADILLA PHARMD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Pharmacist prescribing approach at this San Juan, PR practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among PR prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
